CHIN KOK TIAN

MANAGING DIRECTOR
MY MYRACLE SDN BHD​
​​

KT Chin, who graduated with a Bachelor of Science in Agribusiness (Honors), has been a prominent figure in the business world since 1996. He is the innovative founder of My Myracle Sdn Bhd, a company specialising in the production of postbiotics. My Myracle is at the forefront of postbiotic research in ASEAN, focusing on using Lactobacillus plantarum isolated from local Malaysian fermented foods. These postbiotics are recognized for their health benefits, including gut health promotion, immunity enhancement, inflammation reduction, and potential adjunctive cancer treatments.
He is also a co-founder and Chairman of Eramas Group, which is dedicated to producing and commercialising coconut and palm products and their derivatives, including fatty acids.
 

Speech title & Synopsis

Futuristic 5G Biotic: Innovation in Postbiotic Production

Focusing on the pioneering production of Postbiotics by My Myracle Sdn Bhd using Lactobacillus plantarum, isolated from traditional Malaysian fermented foods. This innovative research of 20+ years by a Professor from University Putra Malaysia has led to the registration of two significant patents, one for a nutraceutical product that promotes gut health, boosts immunity, and reduces inflammation, and the other for a tumour cytotoxic agent, offering potential as an adjunctive cancer treatment.
Our groundbreaking approach involves a unique low-temperature fermentation technique that preserves the viability of Lactobacillus plantarum without heat-killing, ensuring the integrity and efficacy of the postbiotics. This method stands out in the field, providing superior health benefits compared to conventional techniques. It will delve into the science behind this novel fermentation process, the health benefits of the resulting postbiotics, and the promising applications in both nutraceuticals and oncology.